Ran Jing et al. reported that NAD+ is a potential therapeutic target for mtDNA depletion syndrome, suggesting that DGUOK could involve in NAD biosynthesis (17). This evidence concerns the gene DGUOK and mitochondrial DNA depletion syndrome.